Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.8%

- Check8 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision (v3.7.0) was added to the study record history, and the prior revision (v3.6.6) was removed from the history list. This reflects an update to the record's version history rather than substantive changes to the study data.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history and the previous revision (v3.6.5) was removed from the current history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study record history shows a new revision entry, 'Revision: v3.6.5', added to replace the previous 'Revision: v3.6.4'. This documents an updated version of the study record.SummaryDifference0.1%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.